SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 133 filers reported holding SANA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,294,767 | -34.7% | 592,963 | +0.5% | 0.00% | – |
| Q2 2023 | $3,515,345 | +121.3% | 589,823 | +21.4% | 0.00% | – |
| Q1 2023 | $1,588,373 | -10.3% | 485,741 | +8.4% | 0.00% | – |
| Q4 2022 | $1,770,208 | -57.6% | 448,154 | -35.6% | 0.00% | -100.0% |
| Q3 2022 | $4,171,000 | -30.0% | 695,385 | -25.0% | 0.00% | 0.0% |
| Q2 2022 | $5,961,000 | -59.6% | 927,023 | -48.1% | 0.00% | -50.0% |
| Q1 2022 | $14,753,000 | +30.4% | 1,785,893 | +144.4% | 0.00% | +100.0% |
| Q4 2021 | $11,313,000 | -44.1% | 730,777 | -18.7% | 0.00% | -66.7% |
| Q3 2021 | $20,235,000 | +19.8% | 898,490 | +4.6% | 0.00% | +50.0% |
| Q2 2021 | $16,894,000 | -38.1% | 859,308 | +5.4% | 0.00% | -50.0% |
| Q1 2021 | $27,295,000 | – | 815,520 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 34,239,018 | $673,139,000 | 8.60% |
| Trustees of Columbia University in the City of New York | 281,250 | $5,530,000 | 8.17% |
| Crestline Management, LP | 3,210,937 | $63,127,000 | 5.44% |
| Omega Fund Management, LLC | 843,750 | $16,588,000 | 1.88% |
| Alphabet Inc. | 2,812,500 | $55,294,000 | 1.13% |
| SB Management Ltd | 2,625,153 | $51,611,000 | 0.61% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 4,508,111 | $88,629,000 | 0.53% |
| HARVARD MANAGEMENT CO INC | 468,749 | $9,216,000 | 0.53% |
| Avidity Partners Management LP | 778,597 | $15,307,000 | 0.41% |
| Dragoneer Investment Group | 1,500,000 | $29,490,000 | 0.38% |